COM:SAMSUNGBIOLOGICS
Samsung Biologics
- Stock
Last Close
932K
22/11 06:30
Market Cap
58.01T
Beta: -
Volume Today
79.87K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -99.69B - | 1.90T 2,010.90% | -176.82B 109.28% | -96.97B 45.16% | 224.11B 331.11% | 202.90B 9.46% | 240.97B 18.76% | 393.59B 63.33% | 798.06B 102.76% | 857.69B 7.47% | |
depreciation and amortization | 26.35B - | 41.63B 57.98% | 60.15B 44.49% | 69.93B 16.25% | 91.45B 30.78% | 132.89B 45.31% | 143.69B 8.13% | 161.79B 12.60% | 308.26B 90.54% | 489.78B 58.88% | |
deferred income tax | |||||||||||
stock based compensation | |||||||||||
change in working capital | -34.19B - | -95.96B 180.67% | -73.85B 23.03% | 22.28B 130.17% | -188.98B 948.24% | -187.89B 0.58% | -203.53B 8.33% | -234.84B 15.38% | -263.49B 12.20% | 298.74B 213.38% | |
accounts receivables | -121.66B - | -107.53B 11.62% | -176.65B 64.28% | -356.57B 101.85% | -15.57B 95.63% | ||||||
inventory | -52.78B - | -117.24B 122.13% | -44.09B 62.39% | -43.73B 0.82% | -90.44B 106.83% | -156.32B 72.85% | -184.89B 18.27% | -370.57B 100.43% | -179.91B 51.45% | -273.90B 52.24% | |
accounts payables | -150.25M - | 58.25B 38,869.94% | 21.06B 63.85% | 134.59B 539.10% | 267.04B 98.40% | ||||||
other working capital | 18.59B - | 21.28B 14.49% | -29.76B 239.84% | 66.01B 321.77% | -98.54B 249.28% | 90.25B 191.59% | 30.63B 66.07% | 291.32B 851.25% | 138.41B 52.49% | 321.17B 132.05% | |
other non cash items | -772.48M - | -2.12T 273,840.63% | 127.86B 106.04% | 154.58B 20.90% | -159.00B 202.86% | -137.75B 13.36% | 20.96B 115.22% | 134.06B 539.53% | 110.21B 17.79% | 20.01B 81.84% | |
net cash provided by operating activities | -108.30B - | -265.51B 145.17% | -62.66B 76.40% | 149.82B 339.09% | -32.42B 121.64% | 10.15B 131.32% | 202.09B 1,890.33% | 454.60B 124.95% | 953.05B 109.65% | 1.67T 74.83% | |
investments in property plant and equipment | -576.78B - | -392.97B 31.87% | -168.17B 57.21% | -504.80B 200.17% | -284.46B 43.65% | -181.20B 36.30% | -148.57B 18.01% | -421.15B 183.48% | -1.01T 139.63% | -1.11T 9.52% | |
acquisitions net | -1K - | -35.47B 3,546,880,000% | -234.65B 561.58% | -200.01B 14.76% | 743.06B 471.50% | -18.10B 102.44% | 8.90B 149.18% | -12.38B 239.03% | -1.10T 8,767.32% | -1.08T 1.59% | |
purchases of investments | -9M - | -149.12B 1,656,839.07% | -970B 550.46% | -1.30T 34.02% | -4.57T 251.58% | -4.32T 5.48% | -4.38T 1.39% | -5.84T 33.33% | -12.43T 112.81% | -7.85T 36.84% | |
sales maturities of investments | -207.87B - | 1M 100.00% | 5.18B 517,812.59% | 2.27T 43,729.81% | 3.48T 53.30% | 4.88T 40.23% | 4.11T 15.78% | 5.34T 29.93% | 11.43T 114.01% | 8.47T 25.92% | |
other investing activites | 202.83B - | 148.08B 26.99% | -5.18B 103.50% | 13.21M - | -21.06B 159,559.03% | -8.85B 57.96% | 37.63M 100.43% | 242.53M 544.42% | 2.78B 1,048.11% | ||
net cash used for investing activites | -581.83B - | -429.48B 26.18% | -1.37T 219.65% | 265.19B 119.32% | -631.99B 338.32% | 339.64B 153.74% | -418.69B 223.27% | -933.49B 122.96% | -3.11T 232.78% | -1.57T 49.58% | |
debt repayment | -52.01B - | -93.36B 79.50% | -51.11B 45.25% | -467.10B 813.92% | -68.75B 85.28% | -386.58B 462.30% | -401.65B 3.90% | -190.98B 52.45% | -937.34B 390.81% | -1.28T 36.65% | |
common stock issued | 334.55B - | 267.03B 20.18% | 1.48T 455.85% | 3.20T - | |||||||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 399.48B - | 459.55B 15.04% | 198.14B 56.88% | 179.92B 9.19% | 392.69B 118.25% | 146.78B 62.62% | 524.21B 257.15% | 687.60B 31.17% | 736.67B 7.14% | 645.79B 12.34% | |
net cash used provided by financing activities | 682.02B - | 633.22B 7.16% | 1.63T 157.62% | -287.18B 117.60% | 323.94B 212.80% | -239.81B 174.03% | 122.56B 151.11% | 496.62B 305.21% | 3.00T 504.10% | -635.05B 121.17% | |
effect of forex changes on cash | -114.60K - | 78.25K 168.28% | 21.66M 27,582.66% | -75.51M 448.59% | 10 100.00% | -2.51B 25,112,250,100% | -2.21B 11.80% | 831.10M 137.52% | -3.24B 490.05% | 12.24B 477.72% | |
net change in cash | -8.11B - | -61.78B 661.42% | 195.83B 416.99% | 127.75B 34.76% | -340.47B 366.51% | 107.48B 131.57% | -96.25B 189.55% | 18.56B 119.28% | 843.41B 4,444.17% | -522.88B 162.00% | |
cash at beginning of period | 104.40B - | 96.29B 7.77% | 34.51B 64.16% | 230.34B 567.45% | 358.09B 55.46% | 17.62B 95.08% | 125.10B 609.92% | 28.85B 76.94% | 47.41B 64.33% | 890.82B 1,778.95% | |
cash at end of period | 96.29B - | 34.51B 64.16% | 230.34B 567.45% | 358.09B 55.46% | 17.62B 95.08% | 125.10B 609.92% | 28.85B 76.94% | 47.41B 64.33% | 890.82B 1,778.95% | 367.94B 58.70% | |
operating cash flow | -108.30B - | -265.51B 145.17% | -62.66B 76.40% | 149.82B 339.09% | -32.42B 121.64% | 10.15B 131.32% | 202.09B 1,890.33% | 454.60B 124.95% | 953.05B 109.65% | 1.67T 74.83% | |
capital expenditure | -576.78B - | -392.97B 31.87% | -168.17B 57.21% | -504.80B 200.17% | -284.46B 43.65% | -181.20B 36.30% | -148.57B 18.01% | -421.15B 183.48% | -1.01T 139.63% | -1.11T 9.52% | |
free cash flow | -685.08B - | -658.48B 3.88% | -230.83B 64.94% | -354.99B 53.78% | -316.88B 10.74% | -171.04B 46.02% | 53.52B 131.29% | 33.44B 37.52% | -56.18B 267.97% | 560.90B 1,098.44% |
All numbers in (except ratios and percentages)